These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27788715)

  • 1. [Autophagy and nonalcoholic fatty liver disease].
    Li XQ; Wang W; Jia YH; Zhao CY
    Zhonghua Gan Zang Bing Za Zhi; 2016 Aug; 24(8):632-635. PubMed ID: 27788715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease.
    Liu C; Liao JZ; Li PY
    World J Gastroenterol; 2017 Mar; 23(11):1964-1973. PubMed ID: 28373762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of Autophagy in Nonalcoholic Fatty Liver Disease.
    Czaja MJ
    Dig Dis Sci; 2016 May; 61(5):1304-13. PubMed ID: 26725058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy, NAFLD and NAFLD-Related HCC.
    Wu WKK; Zhang L; Chan MTV
    Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysregulation of autophagy acts as a pathogenic mechanism of non-alcoholic fatty liver disease (NAFLD) induced by common environmental pollutants.
    Zhang Y; Li K; Kong A; Zhou Y; Chen D; Gu J; Shi H
    Ecotoxicol Environ Saf; 2021 Jul; 217():112256. PubMed ID: 33901779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free radical biology for medicine: learning from nonalcoholic fatty liver disease.
    Serviddio G; Bellanti F; Vendemiale G
    Free Radic Biol Med; 2013 Dec; 65():952-968. PubMed ID: 23994574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2E1 and oxidant stress in alcoholic and non-alcoholic fatty liver disease.
    Leung TM; Nieto N
    J Hepatol; 2013 Feb; 58(2):395-8. PubMed ID: 22940046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoplasmic Reticulum Stress Related Molecular Mechanisms in Nonalcoholic Fatty Liver Disease (NAFLD).
    Wang L; Chen J; Ning C; Lei D; Ren J
    Curr Drug Targets; 2018; 19(9):1087-1094. PubMed ID: 29766802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen peroxide impairs autophagic flux in a cell model of nonalcoholic fatty liver disease.
    Jiang P; Huang Z; Zhao H; Wei T
    Biochem Biophys Res Commun; 2013 Apr; 433(4):408-14. PubMed ID: 23537653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
    Zhang Y; Chen Y
    Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rutin exhibits hepatoprotective effects in a mouse model of non-alcoholic fatty liver disease by reducing hepatic lipid levels and mitigating lipid-induced oxidative injuries.
    Liu Q; Pan R; Ding L; Zhang F; Hu L; Ding B; Zhu L; Xia Y; Dou X
    Int Immunopharmacol; 2017 Aug; 49():132-141. PubMed ID: 28577437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy and non-alcoholic fatty liver disease.
    Lavallard VJ; Gual P
    Biomed Res Int; 2014; 2014():120179. PubMed ID: 25295245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron and non-alcoholic fatty liver disease.
    Britton LJ; Subramaniam VN; Crawford DH
    World J Gastroenterol; 2016 Sep; 22(36):8112-22. PubMed ID: 27688653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoplasmic reticulum proteostasis in hepatic steatosis.
    Baiceanu A; Mesdom P; Lagouge M; Foufelle F
    Nat Rev Endocrinol; 2016 Dec; 12(12):710-722. PubMed ID: 27516341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy in nonalcoholic steatohepatitis.
    Amir M; Czaja MJ
    Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):159-66. PubMed ID: 21476911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of JNK suppresses autophagy and attenuates insulin resistance in a rat model of nonalcoholic fatty liver disease.
    Yan H; Gao Y; Zhang Y
    Mol Med Rep; 2017 Jan; 15(1):180-186. PubMed ID: 27909723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
    Han YH; He XM; Jin MH; Sun HN; Kwon T
    Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism.
    Zhou Y; Ding YL; Zhang JL; Zhang P; Wang JQ; Li ZH
    Biomed Pharmacother; 2018 Jan; 97():1397-1408. PubMed ID: 29156529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.